CTOs on the Move

CytRx Corporation

www.cytrx.com

 
CytRx Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Los Angeles, CA. To find more information about CytRx Corporation, please visit www.cytrx.com
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.cytrx.com
  • 11726 San Vicente Blvd Ste 650
    Los Angeles, CA USA 90049-5079
  • Phone: 310.826.5648

Executives

Name Title Contact Details

Similar Companies

Cure International

Cure International is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Lemoyne, PA. To find more information about Cure International, please visit www.cureinternational.org

Hendrick Health System

For more than 85 years, the Hendrick name has been the first name in healthcare in Abilene, Texas, and the Texas Midwest. As the first healthcare network to establish a true system of services, the Hendrick name reigns over a 522-bed medical center, a women’s center, rehabilitation hospital, cancer center and numerous other innovative services. Hendrick was the first hospital to permanently serve the Texas Midwest when its doors opened in 1924. During the Great Depression, it was the first hospital people of the Big Country area rallied behind to keep the doors open when money was scarce. Mr. and Mrs. Thomas Hendrick, for whom the institution was named, made the first major financial gift to the hospital. Through the years it has been the first in the area to offer specialized services, creating departments to fill needs such as physical medicine, nuclear medicine, spiritual care and much more.

Cerebral

Cerebral is a mental health company dedicated to improving access to treatment for anxiety and depression.

Mount Saint Mary's Hospital

Mount Saint Mary's Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Mount Saint Mary's Hospital is based in Lewiston, NY. You can find more information on Mount Saint Mary's Hospital at www.msmh.org

Scynexis

SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.